IBM Triumphs in Legal Battle Against LzLabs Over Trade Secret Theft
March 10, 2025 - 19:48
In a significant legal victory, IBM has successfully secured a ruling in a London court against LzLabs, a company linked to U.S. entrepreneur John Moores. The lawsuit, which centered around allegations of trade secret theft, was brought to the High Court in England. IBM accused LzLabs, along with its English subsidiaries, of illicitly utilizing proprietary technology from IBM's mainframe systems.
The case highlighted that LzLabs' UK subsidiary, Winsopia, had acquired an IBM mainframe computer and entered into a licensing agreement with IBM back in 2013. However, IBM claimed that instead of adhering to the terms of the license, Winsopia engaged in reverse-engineering IBM's mainframe software, thereby infringing on IBM's intellectual property rights.
This ruling underscores the ongoing challenges in the tech industry regarding the protection of trade secrets and proprietary technology, emphasizing the importance of legal frameworks in safeguarding innovation and intellectual property.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...